Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) proteolysis in patients with colorectal cancer: Possible association with the metastatic potential of the tumor

International Journal of Cancer

Volumn 79, Issue 5, 1998, Pages 460-467

  Baciuchka, Marjorie ^a   Remacle Bonnet, Maryse ^b   Garrouste, Françoise ^b   Favre, Roger ^a   Sastre, Bernard ^c   Pommier, Gilbert ^b  

^a TIMONE HOSPITAL   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c Service de Chirurgie Digestive   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3;

ADULT; AGED; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; COLORECTAL CANCER; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; METASTASIS; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING;

ADENOCARCINOMA; AGED; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; ENDOPEPTIDASES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PEPTIDE FRAGMENTS; PROTEASE INHIBITORS;

EID: 0031708907     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981023)79:5<460::AID-IJC3>3.0.CO;2-Z     Document Type: Article

References (24)

1. BLAT, C., VILLAUDY, J. and BINOUX, M., In vivo proteolysis of serum insulin-like growth factor (IGF)-binding protein-3 results in increased availability of IGF to target cells. J. clin. Invest., 93, 2286-2290 (1994).
2. COHEN, P., PEEHL, D.M., STAMEY, T.A., WILSON, K.F., CLEMMONS, D.R. and ROSENFELD, R.G., Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients. J. clin. Endocrinol. Metab., 76, 1031-1035 (1993).
3. CULOUSCOU, J.M., REMACLE-BONNET, M., GARROUSTE, F., FANTINI, J., MARVALDI, J. and POMMIER, G., Production of insulin-like growth factor II (IGF-II) and different forms of IGF-binding proteins by HT-29 human colon carcinoma cell line. J. cell. Physiol., 143, 405-415 (1990).
4. EL-ATIQ, F., GARROUSTE, F., REMACLE-BONNET, M., SASTRE, B. and POMMIER, G., Alterations in serum levels of insulin-like growth factors and insulin-like growth factor binding proteins in patients with colorectal cancer. Int. J. Cancer, 57, 491-497 (1994).
5. FROST, V.J., HELLE, S.I., LONNING, P.E., VAN DER STAPFEN, J.W.J. and HOLLY, J.M., Effects of treatment with megestrol acetate, aminoglutimide, or formestane on insulin-like growth (IGF) I and II, IGF-binding proteins (IGFBPs), and IGFBP-3 protease status in patients with advanced breast cancer. J. clin. Endocrinol. Metab., 81, 2216-2221 (1996).
6. HOLLY, J.M.P., The insulin-like growth factors in critical illness: pathophysiology and therapeutic potential. Proc. Nutrition. Soc., 54, 591-599 (1995).
7. HOSSENLOPP, P., SEGOVIA, B., LASARRE, C., ROGHANI, M., BREDON, M. and BINOUX, M., Evidence of enzymatic degradation of insulin-like growth factor binding proteins in the 150K complex during pregnancy. J. clin. Endocrinol. Metab., 71, 797-805 (1990).
8. HOSSENLOPP, P., SEURIN, D., SEGOVIA-QUINSON, B., HARDOUIN, S. and BINOUX, M., Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal. Biochem., 154, 138-143 (1986).
9. JONES, J.I. and CLEMMONS, D.R., Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev., 16, 3-34 (1995).
10. KANETY, H., MADJAR, Y., DAGAN, Y., LEVI, J., PAPA, M.Z., PARIENTE, C., GOLDWASSER, B. and KARASIK, A., Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. J. clin. Endocrinol. Metab., 77, 229-233 (1993).
11. LALOU, C. and BINOUX, M., Evidence that limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3) occurs in the normal state outside of the bloodstream. Regul. Pept., 48, 179-188 (1993).
12. LAMBERT, S., COLLETTE, J., GILLIS, J., FRANCHIMONT, P., DESAIVE, C. and GOL-WINKLER, R., Tumor IGF-II content in a patient with a colon adenocarcinoma correlates with abnormal expression of the gene. Int. J. Cancer, 48, 826-830 (1991).
13. LAMSON, G., GIUDICE, L.C. and ROSENFELD, R.G., A simple assay for proteolysis of IGFBP-3. J. clin. Endocrinol. Metab., 72, 1391-1393 (1991).
14. LEE, C.Y. and RECHLER, M.M., Proteolysis of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in 150-kilodalton IGFBP complexes by a cation-dependent protease activity in adult rat serum promotes the release of bound IGF-I. Endocrinology, 137, 2051-2058 (1996).
15. LEROITH, D., WERNER, H., BEITNER-JOHNSON, D. and ROBERTS, JR., C.T., Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev., 16, 143-163 (1995).
16. MÜLLER, H.L., OH, Y., LEHRNBECHER, T., BLUM, W.F. and ROSENFELD, R.G., Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia. J. clin. Endocrinol. Metab., 79, 428-134 (1994).
17. PAPA, P., GLIOZZO, B., CLARK, G.M., MCGUIRE, W.L., MOORE, D., FUJITA-YAMAGUCHI, Y., VIGNERI, R., GOLDFINE, I.D. and PEZZINO, V., Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res., 53, 3736-3740 (1993).
18. POMMIER, G.J., GARROUSTE, F.L., EL ATIQ, F., ROCCABIANCA, M., MARVALDI, J.L. and REMACLE-BONNET, M.M., Potential autocrine role of insulin-like growth-factor-II (IGF-II) during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line. Cancer Res., 52, 3182-3188 (1992).
19. RAJAH, R., KATZ, L., NUNN, S., SOLBERG, P., BEERS, T. and COHEN, P., Insulin-like growth factor binding protein (IGFBP) proteases: functional regulators of cell growth. Progr. Growth Factor Res., 6, 273-284 (1995).
20. REMACLE-BONNET, M., GARROUSTE, F., EL ATIQ, F., ROCCABIANCA, M., MARVALDI, J. and POMMIER, G., Des-(1-3)-IGF-I, an insulin-like growth-factor analog used to mimic a potential IGF-II autocrine loop, promotes the differentiation of human colon carcinoma cells. Int. J. Cancer, 52, 910-917 (1992).
21. REMACLE-BONNET, M.M., GARROUSTE, F.L. and POMMIER, G.J., Surface-bound plasmin induces selective proteolysis of insulin-like growth-factor (IGF)-binding protein-4 (IGFBP-4) and promotes autocrine IGF-II bioavailability in human colon-carcinoma cells. Int. J. Cancer, 72, 835-843 (1997).
22. SINGH, P. and RUBIN, N., Insulin-like growth factors and binding proteins in colon cancer. Gastroenterotogy, 105, 1218-1237 (1993).
23. Xu, S., CWYFAN-HUGHES, S.C., VAN DER STAPFEN, J.W.J., SANSOM, J., BURTON, J.L., DONNELLY, M. and HOLLY, J.M.P., Altered insulin-like growth-factor-II (IGF-II) level and IGF-binding protein-3 (IGFBP-3) protease activity in interstitial fluid taken from the skin lesion of psoriasis. J. invest. Dermatol., 106, 109-112 (1996).
24. Yu, H., LEVESQUE, M.A., KHOSRAVI, M.J., PAPANASTASIOU-DIAMANDI, A., CLARK, G.M. and DIAMANDIS, E.P., Associations between insulin-like growth-factors and their binding proteins and other prognostic indicators in breast cancer. Brit. J. Cancer, 74, 1242-1247 (1996).